 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - Ovid Therapeutics Inc. (OVID)
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2019-10-08 Purchase | 2019-10-10 8:32 pm | Ovid Therapeutics Inc. | OVID | LEVIN JEREMY M CEO 10% Owner | 60,000 | $2.5 | $150,000 | 4,736,529 (Indirect Direct) | View |
| 2019-10-08 Purchase | 2019-11-22 06:23 am | Ovid Therapeutics Inc. | OVID | TAKEDA PHARMACEUTICAL CO LTD MILLENNIUM PHARMACEUTICALS INC 10% Owner | 2,000,000 | $2.5 | $5,000,000 | 5,750,000 (Indirect) | View |
| 2020-08-28 Purchase | 2020-09-01 9:34 pm | Ovid Therapeutics Inc. | OVID | LEVIN JEREMY M CEO 10% Owner | 8,488 | $5.84 | $49,570 | 5,792,530 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2019-04-03 Option Award | 2019-04-08 8:30 pm | N/A 2029-03-24 | Ovid Therapeutics Inc. | OVID | Perone Thomas Michael VP | 125,000 | $1.92 | 125,000 (Direct) | View |
| 2019-06-07 Option Award | 2019-06-10 4:19 pm | N/A 2029-06-06 | Ovid Therapeutics Inc. | OVID | Bernstein Karen Director | 5,813 | $1.6 | 5,813 (Direct) | View |
| 2019-06-07 Option Award | 2019-06-10 4:21 pm | N/A 2029-06-06 | Ovid Therapeutics Inc. | OVID | Duncan Barbara Gayle Director | 5,813 | $1.6 | 5,813 (Direct) | View |
| 2019-06-07 Option Award | 2019-06-10 4:24 pm | N/A 2029-06-06 | Ovid Therapeutics Inc. | OVID | WILLIAMS DOUGLAS E Director | 5,813 | $1.6 | 5,813 (Direct) | View |
| 2019-06-10 Option Award | 2019-08-01 4:58 pm | N/A 2029-06-09 | Ovid Therapeutics Inc. | OVID | Bernstein Karen Director | 5,813 | $1.65 | 5,813 (Direct) | View |
| 2019-06-10 Option Award | 2019-08-01 5:00 pm | N/A 2029-06-09 | Ovid Therapeutics Inc. | OVID | Duncan Barbara Gayle Director | 5,813 | $1.65 | 5,813 (Direct) | View |
| 2019-06-10 Option Award | 2019-08-01 5:01 pm | N/A 2029-06-09 | Ovid Therapeutics Inc. | OVID | WILLIAMS DOUGLAS E Director | 5,813 | $1.65 | 5,813 (Direct) | View |
| 2019-06-10 Option Award | 2019-08-02 8:28 pm | N/A 2029-06-09 | Ovid Therapeutics Inc. | OVID | Friedman Bart Director | 5,813 | $1.65 | 5,813 (Direct) | View |
| 2019-11-01 Option Award | 2019-11-04 5:43 pm | N/A 2029-10-31 | Ovid Therapeutics Inc. | OVID | Daly Timothy VP | 25,000 | $2.46 | 25,000 (Direct) | View |
| 2019-11-01 Option Award | 2019-11-04 5:46 pm | N/A 2029-10-31 | Ovid Therapeutics Inc. | OVID | Rakhit Amit President and CMO | 75,000 | $2.46 | 75,000 (Direct) | View |
| 2019-11-13 Option Award | 2019-11-15 4:22 pm | N/A 2029-11-12 | Ovid Therapeutics Inc. | OVID | Bernstein Karen Director | 7,437 | $2.43 | 7,437 (Direct) | View |
| 2019-11-13 Option Award | 2019-11-15 4:24 pm | N/A 2029-11-12 | Ovid Therapeutics Inc. | OVID | Duncan Barbara Gayle Director | 7,437 | $2.43 | 7,437 (Direct) | View |
| 2019-11-13 Option Award | 2019-11-15 4:26 pm | N/A 2029-11-12 | Ovid Therapeutics Inc. | OVID | Friedman Bart Director | 7,437 | $2.43 | 7,437 (Direct) | View |
| 2019-11-13 Option Award | 2019-11-15 4:28 pm | N/A 2029-11-12 | Ovid Therapeutics Inc. | OVID | WILLIAMS DOUGLAS E Director | 7,437 | $2.43 | 7,437 (Direct) | View |
| 2019-11-18 Option Award | 2019-11-21 08:59 am | N/A 2029-11-17 | Ovid Therapeutics Inc. | OVID | Tardio Jason Chief Commercial Officer | 125,000 | $2.76 | 125,000 (Direct) | View |
| 2019-12-18 Option Award | 2019-12-20 4:18 pm | N/A 2029-12-17 | Ovid Therapeutics Inc. | OVID | Perone Thomas Michael VP | 100,000 | $4.42 | 100,000 (Direct) | View |
| 2019-12-18 Option Award | 2019-12-20 4:19 pm | N/A 2029-12-17 | Ovid Therapeutics Inc. | OVID | Daly Timothy VP | 125,000 | $4.42 | 125,000 (Direct) | View |
| 2019-12-18 Option Award | 2019-12-20 4:21 pm | N/A 2029-12-17 | Ovid Therapeutics Inc. | OVID | Haasner Dirk VP | 100,000 | $4.42 | 100,000 (Direct) | View |
| 2019-12-18 Option Award | 2019-12-20 4:24 pm | N/A 2029-12-17 | Ovid Therapeutics Inc. | OVID | LEVIN JEREMY M CEO 10% Owner | 600,000 | $4.42 | 600,000 (Direct) | View |
| 2019-12-18 Option Award | 2019-12-20 4:29 pm | N/A 2029-12-17 | Ovid Therapeutics Inc. | OVID | Rakhit Amit President and CMO | 200,000 | $4.42 | 200,000 (Direct) | View |
| 2020-01-01 Option Award | 2020-01-02 7:47 pm | N/A 2030-12-31 | Ovid Therapeutics Inc. | OVID | Perone Thomas Michael General Counsel Secretary | 75,000 | $4.15 | 75,000 (Direct) | View |
| 2020-06-05 Option Award | 2020-06-08 5:36 pm | N/A 2030-06-04 | Ovid Therapeutics Inc. | OVID | Bernstein Karen Director | 13,250 | $5.29 | 13,250 (Direct) | View |
| 2020-06-05 Option Award | 2020-06-08 5:37 pm | N/A 2030-06-04 | Ovid Therapeutics Inc. | OVID | Duncan Barbara Gayle Director | 13,250 | $5.29 | 13,250 (Direct) | View |
| 2020-06-05 Option Award | 2020-06-08 5:38 pm | N/A 2030-06-04 | Ovid Therapeutics Inc. | OVID | Friedman Bart Director | 13,250 | $5.29 | 13,250 (Direct) | View |
| 2020-06-05 Option Award | 2020-06-08 5:39 pm | N/A 2030-06-04 | Ovid Therapeutics Inc. | OVID | WILLIAMS DOUGLAS E Director | 13,250 | $5.29 | 13,250 (Direct) | View |
| 2020-06-19 Option Award | 2020-06-23 4:33 pm | 2020-06-19 2030-06-18 | Ovid Therapeutics Inc. | OVID | Tardio Jason Chief Commercial Officer | 50,000 | $7.4 | 50,000 (Direct) | View |
| 2020-09-30 Option Award | 2020-10-02 9:40 pm | N/A 2030-09-29 | Ovid Therapeutics Inc. | OVID | Rona Jeffrey A Chief Business Officer | 325,000 | $5.74 | 325,000 (Direct) | View |
| 2020-10-11 Option Award | 2020-10-13 4:38 pm | N/A 2030-10-10 | Ovid Therapeutics Inc. | OVID | Perone Thomas Michael General Counsel Secretary | 20,000 | $5.65 | 20,000 (Direct) | View |
| 2020-10-11 Option Award | 2020-10-13 4:41 pm | N/A 2030-10-10 | Ovid Therapeutics Inc. | OVID | Haasner Dirk VP | 20,000 | $5.65 | 20,000 (Direct) | View |
| 2020-10-11 Option Award | 2020-10-13 4:46 pm | N/A 2030-10-10 | Ovid Therapeutics Inc. | OVID | Rona Jeffrey A Chief Business Officer | 20,000 | $5.65 | 20,000 (Direct) | View |
| 2020-12-17 Option Award | 2020-12-21 4:34 pm | N/A 2030-12-16 | Ovid Therapeutics Inc. | OVID | Daly Timothy VP | 125,000 | $2.82 | 125,000 (Direct) | View |
| 2020-12-17 Option Award | 2020-12-21 4:38 pm | N/A 2030-12-16 | Ovid Therapeutics Inc. | OVID | Haasner Dirk VP | 100,000 | $2.82 | 100,000 (Direct) | View |
| 2020-12-17 Option Award | 2020-12-21 4:45 pm | N/A 2030-12-16 | Ovid Therapeutics Inc. | OVID | LEVIN JEREMY M CEO 10% Owner | 650,000 | $2.82 | 650,000 (Direct) | View |
| 2020-12-17 Option Award | 2020-12-21 4:53 pm | N/A 2030-12-16 | Ovid Therapeutics Inc. | OVID | Rakhit Amit President and CMO | 200,000 | $2.82 | 200,000 (Direct) | View |
| 2020-12-17 Option Award | 2020-12-21 4:58 pm | N/A 2030-12-16 | Ovid Therapeutics Inc. | OVID | Rona Jeffrey A Chief Business Officer | 175,000 | $2.82 | 175,000 (Direct) | View |
| 2020-12-17 Option Award | 2020-12-21 5:04 pm | N/A 2030-12-16 | Ovid Therapeutics Inc. | OVID | Perone Thomas Michael General Counsel Secretary | 175,000 | $2.82 | 175,000 (Direct) | View |
| 2020-12-17 Option Award | 2020-12-21 5:08 pm | N/A 2030-12-16 | Ovid Therapeutics Inc. | OVID | Tardio Jason Chief Commercial Officer | 175,000 | $2.82 | 175,000 (Direct) | View |